Rongxi Shen
Overview
Explore the profile of Rongxi Shen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
105
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ouyang Y, Shen R, Chu L, Fu C, Hu W, Huang H, et al.
Sci Rep
. 2024 Jul;
14(1):15037.
PMID: 38951569
The NK cell is an important component of the tumor microenvironment of pancreatic ductal adenocarcinoma (PDAC), also plays a significant role in PDAC development. This study aimed to explore the...
2.
Wang S, Zhang X, Zou X, Wen M, Gan C, Jiang X, et al.
Cancer Immunol Immunother
. 2022 Nov;
72(5):1301-1313.
PMID: 36436020
Adoptive cell therapy (ACT) with expanded tumor-infiltrating lymphocytes (TIL) or TCR gene-modified T cells (TCR-T) that recognize mutant KRAS neo-antigens can mediate tumor regression in patients with advanced pancreatic ductal...
3.
Wang X, Miao J, Wang S, Shen R, Zhang S, Tian Y, et al.
Mol Cancer
. 2022 Jun;
21(1):133.
PMID: 35733218
Background: Undifferentiated carcinoma with osteoclast-like giant cells (OGCs) of pancreas (UCOGCP) is a rare subtype of pancreatic ductal adenocarcinoma (PDAC), which had poorly described histopathological and clinical features. Methods: In...
4.
Wang X, Zhu D, Bao W, Li M, Wang S, Shen R
Front Surg
. 2021 Dec;
8:771587.
PMID: 34881287
Studies investigating prognostic factors of solid pseudopapillary neoplasm (SPN) have been published with conflicting findings. Retrospective analysis of 63 consecutive cases of SPN in our institution from January 2010 to...
5.
Wang X, Zhu D, Bao W, Li M, Wang S, Shen R
Front Oncol
. 2021 Nov;
11:729151.
PMID: 34733780
Background: Solid pseudopapillary neoplasm (SPN) of the pancreas shows an indolent clinical behavior in cases undergoing surgical resection. The efficacy of combination therapy in the metastatic extrapancreatic SPN treatment remains...
6.
Li M, Shen R, Wang S, Zhu D, Wang X
Asian J Surg
. 2021 Jun;
45(1):137-142.
PMID: 34116862
Background: s As a curative surgical procedure for pancreatic neck-body cancer with invasion to celiac artery (CA), the security and efficacy of distal pancreatectomy (DP) with en bloc resection of...
7.
Shen R, Wang X, Wang S, Zhu D, Li M
Pancreas
. 2021 May;
50(4):617-624.
PMID: 33939677
Objectives: As one of the most aggressive human tumors, pancreatic cancer (PC) is accompanied by poor treatment and prognosis. Although emerging evidence has highlighted the importance of long noncoding RNAs...
8.
Li M, Wang X, Shen R, Wang S, Zhu D
Am Surg
. 2020 May;
86(4):293-299.
PMID: 32391752
Early initiation of chemotherapy could improve overall survival after pancreaticoduodenectomy (PD). The concept of enhanced recovery after surgery (ERAS), which aims to reduce the stress response to surgery and accelerate...
9.
Shen R, Xie F, Shen H, Liu Q, Zheng T, Kou X, et al.
PLoS One
. 2013 Feb;
8(2):e56542.
PMID: 23437163
LIV-1, a zinc transporter, is a mediator downstream of STAT3 both in zebrafish and mammalian cells, and is involved in epithelial-mesenchymal transition (EMT). Despite LIV-1 participates in cancer growth and...
10.
Xie F, Yan L, Lu J, Zheng T, Shi C, Ying J, et al.
PLoS One
. 2013 Feb;
8(1):e54773.
PMID: 23382964
Purpose: The effectiveness of nucleoside analogue on patients with chronic hepatitis B-associated liver failure is still controversial. To address this issue, we did a review of the literatures and analyzed...